Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0108 | 1 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0108 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0066 | 0.2407 | 0.2407 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0108 | 1 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0054 | 0.0151 | 0.0151 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0108 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0095 | 0.7743 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0108 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0053 | 0 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0108 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0108 | 1 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0108 | 1 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0108 | 1 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0108 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0108 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0108 | 1 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0108 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0108 | 1 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0108 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0095 | 0.7743 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0053 | 0 | 0.5 |
Chlamydia trachomatis | sulfite reductase | 0.0066 | 0.2407 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0108 | 1 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0108 | 1 | 1 |
Leishmania major | p450 reductase, putative | 0.0108 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0108 | 1 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0108 | 1 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0108 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
KA (binding) | = 13.8 uM | Activation of human recombinant CA9 catalytic domain by stopped flow CO2 hydration assay | ChEMBL. | 19345095 |
KA (binding) | = 19.6 uM | Activation of human recombinant CA2 by stopped flow CO2 hydration assay | ChEMBL. | 19345095 |
KA (binding) | = 55.7 uM | Activation of human recombinant CA1 by stopped flow CO2 hydration assay | ChEMBL. | 19345095 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.